Speaking at the launch event, Murmu said indigenous development of the therapy was an example of the Make in India initiative
CAR-T therapy is seen to be on the verge of a breakthrough, raising hopes for both cancer patients as well as medical tourism. But can it become the first line of treatment?
How will Uttarakhand's UCC change things? Can insurtech drive up insurance penetration in India? Will Sebi's new disclosure norms affect FII flows? What is CAR-T cell therapy? All answers here
One injection will cost Rs 1.25 lakh with effects lasting for two years or more
Pharma firms and start-ups working to launch it within 2 yrs
Laurus labs investment in ImmunoACT is part of the larger strategy to strengthen biologics business of the firm
They said this disease can cause inflammation of heart muscle if left untreated, and is the leading cause of acquired heart disease in children in developed nations
Putting aside prices for a moment, it's been an exciting period for medical progress
Start-up in talks with MNCsto out-license Ossgrow for developed markets